Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03266055

Effects of Blueberry on Gut Microbiota and Metabolic Syndrome

Prebiotic Effects of Blueberry in Overweight/Obese Individuals: Potential Role of the Gut Microbiota in Alleviating the Metabolic Syndrome.

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
59 (actual)
Sponsor
Laval University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

There is growing evidence that nutritional intervention with dietary polyphenols can positively modulate the gut microbiota to improve cardiometabolic health. Whether the beneficial effects of blueberries on obesity and the metabolic syndrome can be linked to their potential impact on the gut microbiota and intestinal integrity remains speculative at this time. Moreover, the mechanisms of action underlying health benefits associated to blueberry consumption are still unknown. The investigators are thus proposing to combine the study of metagenomics, transcriptomics and metabolomics to test whether a prebiotic activity of highbush blueberries can play a role in the prevention of obesity-linked metabolic syndrome in a clinical setting.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT50 g of blueberry powder, taken daily for 8 weeksSubjects will consume blueberry powder during 8 weeks to test the possible effects of blueberries on gut microbiota composition and on metabolic syndrome parameters.
DIETARY_SUPPLEMENT50g of placebo blueberry powder, taken daily for 8 weeksSubjects will consume blueberry placebo powder to test if there is a significant difference on the impact on gut microbiota composition and metabolic syndrome parameters between this treatment and the active treatment (blueberry powder).

Timeline

Start date
2017-09-01
Primary completion
2019-01-14
Completion
2025-12-01
First posted
2017-08-29
Last updated
2025-12-26

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03266055. Inclusion in this directory is not an endorsement.